We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Net cash provided by operating and investing activities was $15.8 million in the second quarter and net cash used by operating and investing activities was $57.3 million for the first six months...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.47 | 7.19882468168 | 20.42 | 22.71 | 20.145 | 252940 | 21.46955891 | CS |
4 | 0.77 | 3.64583333333 | 21.12 | 22.83 | 20.12 | 255681 | 21.39682258 | CS |
12 | 0.48 | 2.24194301728 | 21.41 | 25.42 | 19.04 | 361503 | 21.65029286 | CS |
26 | -4.02 | -15.5152450791 | 25.91 | 26.75 | 18.69 | 466508 | 22.0246012 | CS |
52 | -29.97 | -57.7902043965 | 51.86 | 55.89 | 18.69 | 629751 | 30.70846154 | CS |
156 | -53.76 | -71.0641110377 | 75.65 | 79.749 | 18.69 | 527408 | 42.22520397 | CS |
260 | 13.13 | 149.885844749 | 8.76 | 79.749 | 6.44 | 441470 | 36.86332324 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions